Results 81 to 90 of about 917,566 (209)

Mutational status in patients with systemic mastocytosis.

, 2012
ISM, indolent systemic mastocytosis; SM-AHNMD, Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease; wt, wild-type.*UPD2pterp13.1 (homozygous DNMT3A mutation).†UPD4q12qter (homozygous KIT and TET2 mutation).‡Patients ...
Valeria Visconte (143692), Paul Elson (143703), Fred H. Hsieh (143706), Matt Kalaycio (143712), Ramon V. Tiu (143732), Jaroslaw P. Maciejewski (81785), Alan E. Lichtin (143714), Hien K. Duong (143717), Yingchun Han (143704), Raghuveer Singh Mali (143710), Reuben Kapur (143722), Sara T. Olalla Saad (143727), Hideki Makishima (143698), Anjali S. Advani (143716), Mikkael A. Sekeres (143708), Anna M. Jankowska (143695), Fabiola Traina (143689), Edward Copelan (143719), Christine L. O’Keefe (143701)   +18 more
core   +1 more source

Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin [PDF]

, 2016
Systemic mastocytosis is a myeloproliferative neoplasm with varying presentation that is caused by infiltration of neoplastic mast cells into extracutaneous tissues.
Borate, Uma, Tsai, Michaela, Josephson, Neil, Mehta, Amitkumar, Schnadig, Ian, Reddy, Vishnu   +5 more
core   +1 more source

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia

Case Reports in Medicine, 2014
Mastocytosis is a myeloproliferative neoplasm characterized by clonal expansion of abnormal mast cells, ranging from the cutaneous forms of the disease to mast cell leukemia.
Theodoros Iliakis, Niki Rougkala, Panagiotis T. Diamantopoulos, Vasiliki Papadopoulou, Fani Kalala, Konstantinos Zervakis, Nefeli Giannakopoulou, Polixeni Chatzinikolaou, Georgia Levidou, Eleftheria Lakiotaki, Penelope Korkolopoulou, Efstratios Patsouris, Eleni Variami, Nora-Athina Viniou   +13 more
doaj   +1 more source

Systemic Mastocytosis: A Mimicker of Reactive Arthritis

, 2023
Objectives. Illustration of a case of systemic mastocytosis mimicking reactive arthritis in the absence of an infectious etiology. Methods. Review of the patient’s medical records. Results.
Jean El-Cheikh, Oussama G. Nasrallah, Mira Merashli, Razan Mohty   +3 more
core   +1 more source

Chronic Anaphylaxis With Indolent Systemic Mastocytosis: A Case Report

Case Reports in Hematology
Systemic mastocytosis is a rare, clonal mast cell disease neoplasm driven by the KIT D816V mutation in greater than 95% of cases. The complex clinical presentation of systemic mastocytosis can make diagnosis challenging.
Sarah Worth, Tracy I. George, Daniel J. Shaheen, Maria Roche, Pankit Vachhani   +4 more
doaj   +1 more source

Mast Cell Leukemia: Review of a Rare Disease and Case Report of Prolonged Survival after Allogeneic Stem Cell Transplant

Human Pathology: Case Reports, 2017
Mast cell leukemia is a rare and aggressive form of mastocytosis characterized by >20% mast cells found in the bone marrow aspirates of patients with signs of systemic mastocytosis-related organ damage.
James Bauer, MD, PhD, Walter Longo, MD, David Yang, MD   +2 more
doaj   +1 more source

Mast Cells in Acute COVID‐19 Patients

Allergy, Volume 81, Issue 8, Page 2984-2989, August 2026.
Ilan Zaffran, Hadas Pahima, Eli Ben‐Chetrit, Amir Jarjoui, Ilaria Puxeddu, Carl Zinner, Joana Vitte, Alexandar Tzankov, Francesca Levi‐Schaffer   +8 more
wiley   +1 more source

Indolent systemic mastocytosis limited to the bone: a case report and review of the literature

São Paulo Medical Journal
CONTEXT Systemic mastocytosis is defined as a clonal disorder of mast cells and their precursor cells and is currently classified as a myeloproliferative neoplasm.
Pedro Pinto-Lopes, Francisco Adao Fonseca, Roberto Silva, Pedro von Hafe, Elsa Fonseca   +4 more
doaj   +1 more source

Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case

Case Reports in Oncological Medicine, 2016
Systemic mastocytosis (SM) is a disease characterized by a clonal infiltration of mast cells affecting various tissues of the body. It is grouped into six different subtypes according to the World Health Organization classification. It is called indolent
Sassine Ghanem, Gwenalyn Garcia, Liu Ying, Matthew Hurford, Marcel Odaimi   +4 more
doaj   +1 more source

Cladribine therapy for systemic mastocytosis

, 2003
Patients with systemic mastocytosis (SM) can suffer from disabling symptoms related to mast cell mediator release or mast cell infiltration, requiring mast cell eradication.
Gerrits, WBJ, Oldhoff, JM; id_orcid, van Dobbenburgh, OA, Pasmans, SG, Kluin-Nelemans, HC, Fijnheer, R, Verhoef, G, van 't Wout, JW, Oldhoff, JM, van Doormaal, JJ   +9 more
core   +1 more source